Literature DB >> 32255046

S100A9-targeted tobacco mosaic virus nanoparticles exhibit high specificity toward atherosclerotic lesions in ApoE-/- mice.

Jooneon Park1, Huiyun Gao, Yunmei Wang, He Hu, Daniel I Simon, Nicole F Steinmetz.   

Abstract

We integrate a biocompatible plant virus-based nanotechnology (tobacco mosaic virus, TMV) with S100A9-targeting peptides for its application in imaging and diagnosis of atherosclerosis. S100A9-targeted TMV nanoparticles exhibit remarkable specificity to S100A9 and targeting of atherosclerosis lesions in ApoE-/- mice.

Entities:  

Year:  2019        PMID: 32255046      PMCID: PMC7147689          DOI: 10.1039/c8tb02276c

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  38 in total

Review 1.  Scavenger receptors in atherosclerosis: beyond lipid uptake.

Authors:  Kathryn J Moore; Mason W Freeman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-05-25       Impact factor: 8.311

2.  Shape effects of filaments versus spherical particles in flow and drug delivery.

Authors:  Yan Geng; Paul Dalhaimer; Shenshen Cai; Richard Tsai; Manorama Tewari; Tamara Minko; Dennis E Discher
Journal:  Nat Nanotechnol       Date:  2007-03-25       Impact factor: 39.213

3.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.

Authors:  Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690

Review 4.  Exploring coronary atherosclerosis with intravascular imaging.

Authors:  Rishi Puri; E Murat Tuzcu; Steven E Nissen; Stephen J Nicholls
Journal:  Int J Cardiol       Date:  2013-04-07       Impact factor: 4.164

5.  S100A8 and S100A9 in human arterial wall. Implications for atherogenesis.

Authors:  Michelle M McCormick; Farid Rahimi; Yuri V Bobryshev; Katharina Gaus; Hala Zreiqat; Hong Cai; Reginald S A Lord; Carolyn L Geczy
Journal:  J Biol Chem       Date:  2005-10-10       Impact factor: 5.157

6.  Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions.

Authors:  Alexis Broisat; Sophie Hernot; Jakub Toczek; Jens De Vos; Laurent M Riou; Sandrine Martin; Mitra Ahmadi; Nicole Thielens; Ulrich Wernery; Vicky Caveliers; Serge Muyldermans; Tony Lahoutte; Daniel Fagret; Catherine Ghezzi; Nick Devoogdt
Journal:  Circ Res       Date:  2012-03-30       Impact factor: 17.367

7.  In Vivo Targeting and Imaging of Atherosclerosis Using Multifunctional Virus-Like Particles of Simian Virus 40.

Authors:  Xianxun Sun; Wei Li; Xiaowei Zhang; Mi Qi; Zhiping Zhang; Xian-En Zhang; Zongqiang Cui
Journal:  Nano Lett       Date:  2016-09-14       Impact factor: 11.189

8.  High levels of myeloid-related protein 14 in human atherosclerotic plaques correlate with the characteristics of rupture-prone lesions.

Authors:  Mihaela G Ionita; Aryan Vink; I Esmé Dijke; Jon D Laman; Wouter Peeters; Petra Homoet van der Kraak; Frans L Moll; Jean-Paul P M de Vries; Gerard Pasterkamp; Dominique P V de Kleijn
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-06-11       Impact factor: 8.311

9.  Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin α4β1.

Authors:  Darren G Woodside; Eric A Tanifum; Ketan B Ghaghada; Ronald J Biediger; Amy R Caivano; Zbigniew A Starosolski; Sayadeth Khounlo; Saakshi Bhayana; Shahrzad Abbasi; John W Craft; David S Maxwell; Chandreshkumar Patel; Igor V Stupin; Deenadayalan Bakthavatsalam; Robert V Market; James T Willerson; Richard A F Dixon; Peter Vanderslice; Ananth V Annapragada
Journal:  Sci Rep       Date:  2018-02-27       Impact factor: 4.379

10.  RGD targeting of human ferritin iron oxide nanoparticles enhances in vivo MRI of vascular inflammation and angiogenesis in experimental carotid disease and abdominal aortic aneurysm.

Authors:  Toshiro Kitagawa; Hisanori Kosuge; Masaki Uchida; Yasunori Iida; Ronald L Dalman; Trevor Douglas; Michael V McConnell
Journal:  J Magn Reson Imaging       Date:  2016-09-30       Impact factor: 4.813

View more
  6 in total

Review 1.  Plant Viruses and Bacteriophage-Based Reagents for Diagnosis and Therapy.

Authors:  Sourabh Shukla; He Hu; Hui Cai; Soo-Khim Chan; Christine E Boone; Veronique Beiss; Paul L Chariou; Nicole F Steinmetz
Journal:  Annu Rev Virol       Date:  2020-09-29       Impact factor: 10.431

Review 2.  Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis.

Authors:  Jun Chen; Xixi Zhang; Reid Millican; Jennifer Sherwood; Sean Martin; Hanjoong Jo; Young-Sup Yoon; Brigitta C Brott; Ho-Wook Jun
Journal:  Adv Drug Deliv Rev       Date:  2021-01-09       Impact factor: 15.470

Review 3.  The pharmacology of plant virus nanoparticles.

Authors:  Christian Isalomboto Nkanga; Nicole F Steinmetz
Journal:  Virology       Date:  2021-01-28       Impact factor: 3.616

Review 4.  Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications.

Authors:  Young Hun Chung; Hui Cai; Nicole F Steinmetz
Journal:  Adv Drug Deliv Rev       Date:  2020-06-27       Impact factor: 15.470

Review 5.  Recent progress in targeted delivery vectors based on biomimetic nanoparticles.

Authors:  Li Chen; Weiqi Hong; Wenyan Ren; Ting Xu; Zhiyong Qian; Zhiyao He
Journal:  Signal Transduct Target Ther       Date:  2021-06-07

Review 6.  Application of Plant Viruses in Biotechnology, Medicine, and Human Health.

Authors:  Srividhya Venkataraman; Kathleen Hefferon
Journal:  Viruses       Date:  2021-08-26       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.